Products for Research Use Only
RegisterLogin

Betifisolimab

CAT: 0804-HY-P99475-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99475-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research[1].
CAS Number
2460539-60-8
Product Name Alternative
MSB-2311
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/betifisolimab.html
Purity
99.04
Solubility
10 mM in DMSO
Smiles
[Betifisolimab]
Molecular Weight
(146.14 kDa)
References & Citations
[1]Xichun Hu, et al. MSB2311, an anti-programmed death-ligand 1 antibody, in advanced solid tumors and hematological malignancies: Safety and tolerability, early anti-cancer activities from a phase I study in Chinese patients. Journal of Clinical Oncology 38, no. 15_suppl.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
abx831788-01Betifisolimab
GTR18337842Betifisolimab Antibody
HV974196-01Research Grade Betifisolimab
E55B0868Betifisolimab (Reference antibody)
ICH5397-5mgBetifisolimab Biosimilar - Research Grade
GTR18697248-01Betifisolimab Chimeric Monoclonal Antibody
A138323Betifisolimab Biosimilar (Monoclonal, IgG1)
GTR18780426-01(Betifisolimab) Biosimilar Reference Antibody
RA0596-01Betifisolimab (Biosimilar Reference Antibody) (PDL1)
A135591Betifisolimab Biosimilar (Monoclonal, IgG1-kappa)

Popular Products